Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression

Journal of Virology

Volumn 85, Issue 8, 2011, Pages 3950-3958

  Ross, P Joel ^a,b   Kennedy, Michael A ^a,b   Christou, Carin ^a   Quiroz, Milagros Risco ^a   Poulin, Kathy L ^a   Parks, Robin J ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CHAPERONE; HELPER DEPENDENT ADENOVIRUS VECTOR; HISTONE; HISTONE CHAPERON HIRA; HISTONE H3; HISTONE H3.3; PROTEIN VII; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; TISSUE CULTURE; TRANSCRIPTION ELONGATION; TRANSGENE;

ADENOVIRUSES, HUMAN; CELL LINE; CHROMATIN; DNA, VIRAL; GENE EXPRESSION; GENETIC VECTORS; HELPER VIRUSES; HUMANS;

ADENOVIRIDAE; ANIMALIA;

EID: 79952824759     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01787-10     Document Type: Article

References (77)

1. Addison, C. L., M. Hitt, D. Kunsken, and F. L. Graham. 1997. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J. Gen. Virol. 78:1653-1661.
2. Ahmad, K., and S. Henikoff. 2002. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol. Cell 9:1191-1200. (Pubitemid 34722299)
3. Amalfitano, A., and R. J. Parks. 2002. Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy. Curr. Gene Ther. 2:111-133.
4. Berk, A. J. 2007. Adenoviridae: the viruses and their replication, p. 2355- 2394. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
5. Beyer, A. L., A. H. Bouton, L. D. Hodge, and O. L. Miller, Jr. 1981. Visualization of the major late R strand transcription unit of adenovirus serotype 2. J. Mol. Biol. 147:269-295.
6. Bramson, J. L., et al. 2004. Helper-dependent adenoviral vectors containing modified fibre for improved transduction of developing and mature muscle cells. Hum. Gene Ther. 15:179-188.
7. Cereghini, S., and M. Yaniv. 1984. Assembly of transfected DNA into chromatin: structural changes in the origin-promoter-enhancer region upon replication. EMBO J. 3:1243-1253.
8. Challberg, M. D., and T. J. Kelly, Jr. 1979. Adenovirus DNA replication in vitro. Proc. Natl. Acad. Sci. U. S. A. 76:655-659.
9. Chatterjee, P. K., M. E. Vayda, and S. J. Flint. 1986. Identification of proteins and protein domains that contact DNA within adenovirus nucleoprotein cores by ultraviolet light crosslinking of oligonucleotides 32P-labelled in vivo. J. Mol. Biol. 188:23-37.
10. Chen, J., N. Morral, and D. A. Engel. 2007. Transcription releases protein VII from adenovirus chromatin. Virology 369:411-422.
11. Chen, Z. Y., C. Y. He, L. Meuse, and M. A. Kay. 2004. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther. 11:856-864.
12. Christou, C., and R. J. Parks. 2011. Rational design of murine secreted alkaline phosphatase for enhanced performance as a reporter gene in mouse gene therapy preclinical trials. Hum. Gene Ther. [Epub ahead of print.] doi:10.1089/HUM-2010-171.
13. Daniell, E., D. E. Groff, and M. J. Fedor. 1981. Adenovirus chromatin structure at different stages of infection. Mol. Cell. Biol. 1:1094-1105.
14. Dery, C. V., et al. 1985. The structure of adenovirus chromatin in infected cells. J. Gen. Virol. 66(Pt. 12):2671-2684.
15. Drane, P., K. Ouararhni, A. Depaux, M. Shuaib, and A. Hamiche. 2010. The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev. 24:1253-1265.
16. Ehrhardt, A., H. Xu, and M. A. Kay. 2003. Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo. J. Virol. 77:7689-7695.
17. Fax, P., O. Lehmkuhler, C. Kuhn, H. Esche, and D. Brockmann. 2000. E1A12S-mediated activation of the adenovirus type 12 E2 promoter depends on the histone acetyltransferase activity of p300/CBP. J. Biol. Chem. 275:40554-40560.
18. Ferrari, R., et al. 2008. Epigenetic reprogramming by adenovirus e1a. Science 321:1086-1088.
19. Ghosh, M. K., and M. L. Harter. 2003. A viral mechanism for remodeling chromatin structure in G0 cells. Mol. Cell 12:255-260.
20. Goldberg, A. D., et al. 2010. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140:678-691.
21. Graham, F. L. 1987. Growth of 293 cells in suspension culture. J. Gen. Virol. 68:937-940.
22. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
23. Hall, C., et al. 2001. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression. Mol. Cell. Biol. 21:1854-1865.
24. Haruki, H., M. Okuwaki, M. Miyagishi, K. Taira, and K. Nagata. 2006. Involvement of template-activating factor I/SET in transcription of adenovirus early genes as a positive-acting factor. J. Virol. 80:794-801. (Pubitemid 43062891)
25. Horwitz, G. A., et al. 2008. Adenovirus small e1a alters global patterns of histone modification. Science 321:1084-1085.
26. Hubberstey, A. V., M. Pavliv, and R. J. Parks. 2002. Cancer therapy utilizing an adenoviral vector expressing only E1A. Cancer Gene Ther. 9:321-329.
27. Jager, L., and A. Ehrhardt. 2009. Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver. Hum. Gene Ther. 20:883-896.
28. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293:1074-1080.
29. Jiang, C., and B. F. Pugh. 2009. Nucleosome positioning and gene regulation: advances through genomics. Nat. Rev. Genet. 10:161-172.
30. Kawase, H., et al. 1996. NAP-I is a functional homologue of TAF-I that is required for replication and transcription of the adenovirus genome in a chromatin-like structure. Genes Cells 1:1045-1056. (Pubitemid 126670808)
31. Komatsu, T., H. Haruki, and K. Nagata. 2011. Cellular and viral chromatin proteins are positive factors in the regulation of adenovirus gene expression. Nucleic Acids Res. 39:889-901.
32. Lacasse, J. J., and L. M. Schang. 2010. During lytic infections, herpes simplex virus type 1 DNA is in complexes with the properties of unstable nucleosomes. J. Virol. 84:1920-1933.
33. Lomvardas, S., and D. Thanos. 2002. Modifying gene expression programs by altering core promoter chromatin architecture. Cell 110:261-271. (Pubitemid 34876553)
34. Loppin, B., et al. 2005. The histone H3.3 chaperone HIRA is essential for chromatin assembly in the male pronucleus. Nature 437:1386-1390. (Pubitemid 41568687)
35. Luger, K., A. W. Mader, R. K. Richmond, D. F. Sargent, and T. J. Richmond. 1997. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389:251-260.
36. Maelandsmo, G. M., et al. 2005. Use of a murine secreted alkaline phosphatase as a non-immunogenic reporter gene in mice. J. Gene Med. 7:307-315. (Pubitemid 40443759)
37. Matsumoto, K., K. Nagata, M. Ui, and F. Hanaoka. 1993. Template activating factor I, a novel host factor required to stimulate the adenovirus core DNA replication. J. Biol. Chem. 268:10582-10587.
38. McLay, D. W., and H. J. Clarke. 2003. Remodelling the paternal chromatin at fertilization in mammals. Reproduction 125:625-633.
39. Mirza, M. A., and J. Weber. 1982. Structure of adenovirus chromatin. Biochim. Biophys. Acta 696:76-86.
40. Morral, N., et al. 1998. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity. Hum. Gene Ther. 9:2709-2716.
41. Muruve, D. A., et al. 2004. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo. J. Virol. 78:5966-5972. (Pubitemid 38661684)
42. Mymryk, J. S., C. J. Fryer, L. A. Jung, and T. K. Archer. 1997. Analysis of chromatin structure in vivo. Methods 12:105-114.
43. Nelson, J. E., and M. A. Kay. 1997. Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication. J. Virol. 71:8902-8907.
44. Ng, P., R. J. Parks, and F. L. Graham. 2002. Preparation of helper-dependent adenoviral vectors. Methods Mol. Med. 69:371-388.
45. Okuwaki, M., A. Iwamatsu, M. Tsujimoto, and K. Nagata. 2001. Identification of nucleophosmin/B23, an acidic nucleolar protein, as a stimulatory factor for in vitro replication of adenovirus DNA complexed with viral basic core proteins. J. Mol. Biol. 311:41-55.
46. Palmer, D., and P. Ng. 2003. Improved system for helper-dependent adenoviral vector production. Mol. Ther. 8:846-852.
47. Palmer, D. J., and P. Ng. 2005. Helper-dependent adenoviral vectors for gene therapy. Hum. Gene Ther. 16:1-16.
48. Parks, R. J., J. L. Bramson, Y. Wan, C. L. Addison, and F. L. Graham. 1999. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors. J. Virol. 73:8027-8034.
49. Parks, R. J., et al. 1996. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. U. S. A. 93:13565-13570.
50. Parks, R. J., and F. L. Graham. 1997. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J. Virol. 71:3293-3298.
51. Pastore, L., et al. 1999. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors. Hum. Gene Ther. 10:1773-1781.
52. Philpott, A., and G. H. Leno. 1992. Nucleoplasmin remodels sperm chromatin in Xenopus egg extracts. Cell 69:759-767.
53. Placek, B. J., et al. 2009. The histone variant H3.3 regulates gene expression during lytic infection with herpes simplex virus type 1. J. Virol. 83:1416-1421.
54. Poleshko, A., et al. 2010. Identification of a functional network of human epigenetic silencing factors. J. Biol. Chem. 285:422-433.
55. Poleshko, A., et al. 2008. Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response. J. Virol. 82:2313-2323. (Pubitemid 351293531)
56. Poulin, K. L., et al. 2010. Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX. J. Virol. 84:10074-10086.
57. Riu, E., D. Grimm, Z. Huang, and M. A. Kay. 2005. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo. Hum. Gene Ther. 16:558-570.
58. Ross, P. J., M. A. Kennedy, and R. J. Parks. 2009. Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression. J. Virol. 83:8409-8417.
59. Ross, P. J., and R. J. Parks. 2009. Construction and characterization of adenovirus vectors. Cold Spring Harb. Protoc. 2009:pdb.prot5011.
60. Ruiz-Lara, S. A., L. Cornudella, and A. Rodriguez-Campos. 1996. Dissociation of protamine-DNA complexes by Xenopus nucleoplasmin and minichromosome assembly in vitro. Eur. J. Biochem. 240:186-194.
61. Russell, W. C. 2009. Adenoviruses: update on structure and function. J. Gen. Virol. 90:1-20.
62. Schiedner, G., et al. 2002. Variables affecting in vivo performance of high-capacity adenovirus vectors. J. Virol. 76:1600-1609. (Pubitemid 34094606)
63. Schiedner, G., et al. 1998. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18:180-183.
64. Schreiner, S., et al. 2010. Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J. Virol. 84:7029-7038.
65. Schwartz, B. E., and K. Ahmad. 2005. Transcriptional activation triggers deposition and removal of the histone variant H3.3. Genes Dev. 19:804-814.
66. Sergeant, A., M. A. Tigges, and H. J. Raskas. 1979. Nucleosome-like structural subunits of intranuclear parental adenovirus type 2 DNA. J. Virol. 29:888-898.
67. Smith, A. C., K. L. Poulin, and R. J. Parks. 2009. DNA genome size affects the stability of the adenovirus virion. J. Virol. 83:2025-2028.
68. Smith, C. L., and G. L. Hager. 1997. Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J. Biol. Chem. 272:27493-27496.
69. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
70. Spector, D. J., J. S. Johnson, N. L. Baird, and D. A. Engel. 2003. Adenovirus type 5 DNA-protein complexes from formaldehyde cross-linked cells early after infection. Virology 312:204-212.
71. Sung, M. T., T. M. Cao, R. T. Coleman, and K. A. Budelier. 1983. Gene and protein sequences of adenovirus protein VII, a hybrid basic chromosomal protein. Proc. Natl. Acad. Sci. U. S. A. 80:2902-2906.
72. Suzuki, M., K. Kasai, and Y. Saeki. 2006. Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin. J. Virol. 80:3293-3300.
73. Tagami, H., D. Ray-Gallet, G. Almouzni, and Y. Nakatani. 2004. Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 116:51-61. (Pubitemid 38156183)
74. Trotman, L. C., N. Mosberger, M. Fornerod, R. P. Stidwill, and U. F. Greber. 2001. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 3:1092-1100.
75. Wong, L. H., et al. 2010. ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res. 20: 351-360.
76. Wong, M. L., and M. T. Hsu. 1988. Psoralen-cross-linking study of the organization of intracellular adenovirus nucleoprotein complexes. J. Virol. 62:1227-1234.
77. Xue, Y., J. S. Johnson, D. A. Ornelles, J. Lieberman, and D. A. Engel. 2005. Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32. J. Virol. 79:2474-2483.